Clinical Trials Directory

Trials / Sponsors / Fondazione Melanoma Onlus

Fondazione Melanoma Onlus

Academic / Other · 7 registered clinical trials — 1 currently recruiting.

StatusTrialPhaseStarted
RecruitingStudy to Evaluate Impact® as Support to Anti PD1 or Anti PD1 Based Regimen Treatment in Patients With Inoperab
Melanoma Metastatic, Locally Advanced Melanoma
N/A2024-08-01
Withdrawn"Dabrafenib and Trametinib in Circulating Free DNA BRAFV600 Mutated Metastatic Melanoma Patients: a Prospectiv
Melanoma
Phase 22021-02-18
Active Not RecruitingNeoadjuvant Plus Adjuvant Treatment With Cemiplimab in Cutaneaous Squamous Cell Carcinoma
Cutaneous Squamous Cell Carcinoma
Phase 22021-02-10
Active Not RecruitingCombination or Sequence of Vemurafenib, Cobimetinib, and Atezolizumab in High-risk, Resectable Melanoma
Melanoma
Phase 22020-10-12
TerminatedVemurafenib Plus Cobimetinib in Advanced or Metastatic Melanoma Patients
Melanoma, Melanoma (Skin), Melanoma Stage
Phase 22018-05-17
CompletedSequential Combo Immuno and Target Therapy (SECOMBIT) Study
Metastatic Melanoma
Phase 22016-11-14
CompletedVemurafenib Plus Cobimetinib Plus PEG-interferon in Advanced Melanoma Patients Harboring the V600BRAF Mutation
Melanoma
Phase 1 / Phase 22014-04-03